1. Home
  2. CFND vs NBY Comparison

CFND vs NBY Comparison

Compare CFND & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CFND

C1 Fund Inc.

HOLD

Current Price

$3.72

Market Cap

27.4M

Sector

N/A

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFND
NBY
Founded
N/A
2000
Country
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
27.4M
31.6M
IPO Year
2025
2007

Fundamental Metrics

Financial Performance
Metric
CFND
NBY
Price
$3.72
$1.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.0K
409.8K
Earning Date
N/A
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.42
EPS
N/A
0.76
Revenue
N/A
$370,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.57
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$0.43
52 Week High
$9.67
$19.95

Technical Indicators

Market Signals
Indicator
CFND
NBY
Relative Strength Index (RSI) 45.07 57.82
Support Level $3.62 $1.01
Resistance Level $4.15 $2.52
Average True Range (ATR) 0.13 0.26
MACD 0.01 0.11
Stochastic Oscillator 48.81 96.45

Price Performance

Historical Comparison
CFND
NBY

About CFND C1 Fund Inc.

C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: